Pascal Biosciences Inc (TSE:NEVI) has released an update.
Nevis Brands Inc reports a significant financial upturn in Q3 2024, with a 345% increase in EBITDA to $104,746 and a shift to a positive net income of $27,873. This performance is attributed to a 9% increase in revenue, improved gross margins, and effective cost management in the cannabis beverage sector.
For further insights into TSE:NEVI stock, check out TipRanks’ Stock Analysis page.